2004International Clinical PsychopharmacologyRequires access

Pharmacology of aripiprazole, a novel antipsychotic: dopamine D2 receptor partial agonist

Tetsuro Kikuchi, Stark Arlene, Frank D. Yocca, Yoshihiro Tadori, Tsuyoshi Hirose, Robert D. McQuade

Open publisher page 0 citations

Abstract

Kikuchi, Tetsuroa; Arlene, Starkb; Yocca, Frankb; Tadori, Yoshihiroa; Hirose, Tsuyoshia; McQuade, Robertb Author Information

About this research paper

What this paper is about

Kikuchi, Tetsuroa; Arlene, Starkb; Yocca, Frankb; Tadori, Yoshihiroa; Hirose, Tsuyoshia; McQuade, Robertb Author Information

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Kikuchi, Tetsuroa; Arlene, Starkb; Yocca, Frankb; Tadori, Yoshihiroa; Hirose, Tsuyoshia; McQuade, Robertb Author Information

Key concepts: Partial agonist, Aripiprazole, Dopamine receptor D2, Pharmacology, Agonist, Antipsychotic, Dopamine receptor D3, Dopamine agonist

Related papers

Back to paper searchBrowse research topicsOriginal source
Pharmacology of aripiprazole, a novel antipsychotic: dopamine D2 receptor partial agonist — Research Paper | ScholarLens